Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNJ6 | P48051 | 15/20 | 0.66 |
| ▸ | KCNJ3 | P48549 | 15/20 | 0.66 |
| ▸ | KCNJ5 | P48544 | 12/20 | 0.66 |
| ▸ | BRAF | P15056 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4648677 | 0.85 | MAPK14 (0.57) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL2240721 | 0.85 | KCNJ6 (0.58) | KCNJ6KCNJ3KCNJ5BRAFCYP3A4 | |
| SCHEMBL2240958 | 0.83 | KCNJ6 (0.56) | KCNJ6KCNJ3KCNJ5BRAFCYP3A4 | |
| SCHEMBL2243108 | 0.81 | MAPK14 (0.59) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL4303949 | 0.80 | KCNJ6 (0.58) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL2246436 | 0.80 | MAPK14 (0.59) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL2243948 | 0.79 | KCNJ6 (0.55) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL13859627 | 0.79 | KCNJ6 (0.69) | KCNJ6KCNJ3KCNJ5BRAF | |
| SCHEMBL2245642 | 0.78 | KCNJ6 (0.60) | KCNJ6KCNJ3KCNJ5BRAFMAPK14 | |
| SCHEMBL14537939 | 0.76 | MAPK13 (0.62) | BRAFMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1960394-A2 | PYRAZOLYL UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | Bayer HealthCare AG (DE) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007059202-A2 | PYRAZOLYL UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | BAYER HEALTHCARE AG (DE) | 2007-05-24 | — | — | WO | disclosed |